Dr. Rajasree P. Chowdry
Claim this profileUniversity Medical Center New Orleans
Studies Cancer
Studies Kidney Cancer
5 reported clinical trials
16 drugs studied
Area of expertise
1Cancer
Stage IV
CD4 count positive
CD4 count negative
2Kidney Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Rajasree P. Chowdry is currently running
Cabozantinib +/− Atezolizumab
for Advanced Kidney Cancer
This phase II trial compares the effect of atezolizumab in combination with usual treatment with cabozantinib to cabozantinib alone in patients with papillary renal cell carcinoma that has spread to other places in the body (metastatic). Papillary renal cell carcinoma (PRCC) is a type of kidney cancer that forms in the lining of the tiny tubes in the kidney that return filtered substances that the body needs back to the blood and remove extra fluid and waste as urine. Most papillary tumors look like long, thin finger-like growths under a microscope. It is also called papillary kidney cancer or PRCC. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply and may also prevent the growth of new blood vessels that tumors need to grow. By these actions it may help slow or stop the spread of cancer cells. Combination therapy with atezolizumab and cabozantinib may shrink the cancer and allow a longer survival time in patients with metastatic renal cell carcinoma.
Recruiting1 award Phase 230 criteria
Durvalumab + Chemotherapy
for Urothelial Carcinoma
This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Recruiting1 award Phase 2 & 310 criteria
More about Rajasree P. Chowdry
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Rajasree P. Chowdry has experience with
- Nivolumab
- Carboplatin
- Paclitaxel
- Ipilimumab
- Cabozantinib
- Cabozantinib S-malate
Breakdown of trials Rajasree P. Chowdry has run
Cancer
Kidney Cancer
Anal Cancer
Anal Carcinoma
Anal Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajasree P. Chowdry specialize in?
Rajasree P. Chowdry focuses on Cancer and Kidney Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are CD4 count positive.
Is Rajasree P. Chowdry currently recruiting for clinical trials?
Yes, Rajasree P. Chowdry is currently recruiting for 3 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Rajasree P. Chowdry has studied deeply?
Yes, Rajasree P. Chowdry has studied treatments such as Nivolumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Rajasree P. Chowdry?
Apply for one of the trials that Rajasree P. Chowdry is conducting.
What is the office address of Rajasree P. Chowdry?
The office of Rajasree P. Chowdry is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.